Extracorporeal magnetic chair in the treatment of various types of urinary incontinence

mmustafa's picture
Musa Saraçoğlu
Sacit Nuri Görgel
Hakan Özturk
Tarık Zengin
Mahmoud Mustafa
Current Affiliation: 
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus. Palestine
Preferred Abstract (Original): 
Objective: To evaluate the usefulness of ext-racorporeal magnetic innervations (ExMI) therapy in the treatment of various types of urinary incontinence(UI) Material and Methods: Total of 88 patients with mean age of 59.76±14.51 (44 male, 44 female) who underwent (ExMI) therapy due UI were included. The patients were diagnosed to have stress UI (53 patients, 60%), mixed UI (24 patients, 27%), true UI (9 patients, 10%) and urge UI (2 patients, 3%). Thirty one patients (35%) had UI after radical Prostatectomy (RP), 13 patients(15%) had UI after
transurethral prostatectomy (TURP), 8 patients (9%) had UI after delivery and 35 patients
(40%) were idiopathic. All patients were primary cases without history of anti-incontinence surgery. All patients have completed 16 sessions of therapy. Each session is 20 minutes and done three times a week. The severity of UI was evaluated using 3 rd ,4 question from ICIQ-SF.
Results: Twenty two patients (25%) were cured, 32 (36%) were improved and 25(28%) partially benefited and 9 (10%) patients had failure of therapy.
Both sexes benefited from the therapy; the male score before and after therapy were 18.25±2.44 and 11.80±5.32 respectively (p=0.001), similarly the female scores before and after therapy were 16.62±4.67 and 7.91±5.32 respectively (p=0.001). The mean values of symptoms score before therapy for patients with history of RP and TURP were 18.00± 2.52 and 18.15±2.41 respectively and the post therapeutic , and 5 th score were 12.44±4.82 and 11.54±5.68 respectively (p=0.001,0.001). Patients with stress or mixed types of UI showed significant improvements after therapy; the symptoms scores before therapy were 17.38±3.7 and 17.00±4.38 respectively and after therapy the score became 9.75±5.18 and 7.83±5.28 respectively (p=0.001, p=0.001). Patients with true incontinence had the least benefit of therapy, the symptoms score before and after therapy were 19.33±2.17 and 16.33±4.47 respectively (p=0.08).
Conclusion: ExMI therapy offers a safe and feasible treatment modality for UI. This kind of therapy is effective for different types of UI which occurred due to various types etiologies including oncologic
surgery. The least benefit of this modality was in patients with true UI. Further studies recruiting larger number of patients with longer follow up period should be carried out to confirm these results.